Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Boreal Genomics
Vancouver, British Columbia, Canada
- Ownership
- Private
- Development stage
- Other
01
Overview
Boreal Genomics commercializes research tools and diagnostic platforms—primarily OnTarget—for highly sensitive detection and monitoring of rare tumor mutations in tissue and plasma, enabling precise tumor profiling and real-time monitoring from cell-free DNA for oncology applications[1][2][4].
- Therapeutic areas
- Oncology
- Modalities
- DeviceDiagnostic assay
- Industry
- Molecular Diagnostics
02
Partnerships
Major unnamed industry partner for commercialization (announced in 2022)[1]
Beyond the preview
Go deeper on Boreal Genomics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Boreal Genomics.